Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch

Yuning Zhou1, Qingding Wang2, Heidi L Weiss1

  • 1Markey Cancer Center, University of Kentucky, Lexington, KY 40536.

Insights

Nuclear factor of activated T-cells 5 (NFAT5) regulates intestinal homeostasis by suppressing mTORC1 and Notch signaling pathways. This finding is crucial for understanding intestinal cell differentiation and function.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Cell Signaling

Background:

  • Intestinal mucosa homeostasis relies on regulated cell turnover.
  • Nuclear factor of activated T-cells 5 (NFAT5) is implicated in intestinal enterocyte differentiation.
  • Signaling pathways critically control intestinal epithelial cell processes.

Purpose of the Study:

  • To investigate the role of NFAT5 in regulating mTOR and Notch signaling pathways in intestinal cells.
  • To elucidate the mechanism by which NFAT5 influences intestinal homeostasis.

Main Methods:

  • Sodium chloride (NaCl) treatment to activate NFAT5.
  • NFAT5 knockdown and overexpression studies.
  • Analysis of REDD1, mTOR, Notch signaling, and MUC2 expression.
  • Inhibition of mTOR signaling with rapamycin.

Main Results:

  • NaCl treatment increased REDD1 and inhibited mTOR signaling, effects dependent on NFAT5.
  • NFAT5 modulated REDD1 expression, impacting mTOR and Notch signaling.
  • NFAT5 regulated goblet cell differentiation marker MUC2 expression via Notch signaling.

Conclusions:

  • NFAT5 plays a significant role in regulating mTOR signaling within intestinal cells.
  • NFAT5 contributes to intestinal homeostasis by suppressing the mTORC1/Notch signaling pathway.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29